Company · CIK 1991792
CG Oncology, Inc.
| CIK | 1991792 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | TX |
| Listed | CGON (Nasdaq) |
| First annual or quarterly report | 2024-03-26 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286230 | 2025-03-28 | 2026-08-06 | 3 | |
| 333-283725 | 2024-12-11 | 2024-12-13 | 4 | |
| 333-276350 | 2024-01-02 | 2024-01-25 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-06 | 424B5Shelf takedown | 333-286230 | 0001193125-26-336792 |
| 2026-01-13 | 424B5Shelf takedown | 333-286230 | 0001193125-26-011846 |
| 2025-03-28 | S-3ASRShelf registered | 333-286230 | 0001193125-25-067207 |
| 2024-12-13 | 424B4Final prospectus | 333-283725 | 0001193125-24-278472 |
| 2024-12-12 | EFFECTDeclared effective | 333-283725 | 9999999995-24-003769 |
| 2024-12-11 | S-1/AAmendment | 333-283725 | 0001193125-24-275552 |
| 2024-12-11 | S-1Registration filed | 333-283725 | 0001193125-24-274822 |
| 2024-11-14 | DRSDraft made public | 377-07557 | 0000950123-24-011900 |
| 2024-01-25 | 424B4Final prospectus | 333-276350 | 0001193125-24-015534 |
| 2024-01-24 | EFFECTDeclared effective | 333-276350 | 9999999995-24-000197 |
| 2024-01-23 | S-1/AAmendment | 333-276350 | 0001193125-24-012523 |
| 2024-01-18 | S-1/AAmendment | 333-276350 | 0001193125-24-009621 |
| 2024-01-02 | S-1Registration filed | 333-276350 | 0001193125-24-000766 |
| 2023-10-27 | DRSDraft made public | 377-06934 | 0000950123-23-009093 |